Publication: 2525

Publication: 2525

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Blood vol 128 (21) 2510-2516

Year:: 2016
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 6

Parents:: 2094 2389
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: Pharmacyclics
Grants:: U10 CA180854, U10 CA180821, U10 CA180836, U10 CA180850, U10 CA180882, U10 CA180833, U10 CA180867, U10 CA180838, U10 CA180866

Corr. Author:
Authors:: Chaitra S. Ujjani Sin-Ho Jung Brandelyn Pitcher Peter Martin Steven I. Park Kristie A. Blum Sonali M. Smith Myron Czuczman Matthew S. Davids Ellis Levine Lionel D. Lewis Scott E. Smith Nancy L. Bartlett John P. Leonard Bruce D. Cheson

Networks:: CAPITAL, IL017, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NH012, LAPS-NY158, LAPS-OH007, NC002, NY018

Study: Alliance-A051103
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1

Keywords:: 29, 8, 39, Clinical Trials and Observations